SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-16-499113
Filing Date
2016-03-10
Accepted
2016-03-10 06:34:21
Documents
88
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d79461d10k.htm 10-K 1490603
2 EX-23.1 d79461dex231.htm EX-23.1 18018
3 EX-31.1 d79461dex311.htm EX-31.1 9500
4 EX-31.2 d79461dex312.htm EX-31.2 9184
5 EX-32.1 d79461dex321.htm EX-32.1 3159
6 EX-32.2 d79461dex322.htm EX-32.2 3205
13 GRAPHIC g79461g78b06.jpg GRAPHIC 83916
  Complete submission text file 0001193125-16-499113.txt   7121234

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT idra-20151231.xml EX-101.INS 1322913
8 XBRL TAXONOMY EXTENSION SCHEMA idra-20151231.xsd EX-101.SCH 88724
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idra-20151231_cal.xml EX-101.CAL 76381
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idra-20151231_def.xml EX-101.DEF 265439
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE idra-20151231_lab.xml EX-101.LAB 569364
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idra-20151231_pre.xml EX-101.PRE 422572
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31918 | Film No.: 161496100
SIC: 2836 Biological Products, (No Diagnostic Substances)